BUZZ-US drugmakers rise on reprieve from Trump tariffs

Reuters2025-04-03

** Shares of major U.S. drugmakers rise between 2% and 3% in early trading amid a broader market selloff

** Johnson & Johnson JNJ.N rises 2.4% to $159.07, Merck MRK.N 2.2% to $88.33, AbbVie ABBV.N 2.5% to $210.28, Amgen AMGN.O 2.3% to $312.23

** The pharma sector ducked U.S. President Donald Trump's sweeping tariffs announced on Wednesday for now

** The news came as "a big positive to the (pharma) sector that has been under pressure from this for the last two weeks," UBS analysts said, adding that AbbVie and Merck, with significant ex-U.S. manufacturing, came out as "big winners"

** However, the administration's call for "robust and resilient domestic manufacturing" in the sector, suggests that it remained on its radar - UBS

** Up to last close, JNJ up 7.4%, AMGN up 17.3%, MRK down ~13%, ABBV up 15.5% so far this year

(Reporting by Mariam Sunny in Bengaluru)

((Mariam.ESunny@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2524268039?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-03 21:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2524268039","market":"us","top_or_hot":-1,"title":"BUZZ-US drugmakers rise on reprieve from Trump tariffs","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-US drugmakers rise on reprieve from Trump tariffs  </title></head><body><p>** Shares of major U.S. drugmakers rise between 2% and 3% in early trading amid a broader market selloff  </p><p>** Johnson &amp; Johnson <span>JNJ.N</span> rises 2.4% to $159.07, Merck <span>MRK.N</span> 2.2% to $88.33, AbbVie <span>ABBV.N</span> 2.5% to $210.28, Amgen <span>AMGN.O</span> 2.3% to $312.23      </p><p>** The <span>pharma sector ducked</span> U.S. President Donald Trump's sweeping tariffs announced on Wednesday for now</p><p>** The news came as \"a big positive to the (pharma) sector that has been under pressure from this for the last two weeks,\" UBS analysts said, adding that AbbVie and Merck, with significant ex-U.S. manufacturing, came out as \"big winners\"</p><p>** However, the administration's call for \"robust and resilient domestic manufacturing\" in the sector, suggests that it remained on its radar - UBS </p><p>** Up to last close, JNJ up 7.4%, AMGN up 17.3%, MRK down ~13%, ABBV up 15.5% so far this year   </p><p> (Reporting by Mariam Sunny in Bengaluru)</p><p> ((Mariam.ESunny@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-US drugmakers rise on reprieve from Trump tariffs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-US drugmakers rise on reprieve from Trump tariffs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-04-03 21:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-US drugmakers rise on reprieve from Trump tariffs  </title></head><body><p>** Shares of major U.S. drugmakers rise between 2% and 3% in early trading amid a broader market selloff  </p><p>** Johnson &amp; Johnson <span>JNJ.N</span> rises 2.4% to $159.07, Merck <span>MRK.N</span> 2.2% to $88.33, AbbVie <span>ABBV.N</span> 2.5% to $210.28, Amgen <span>AMGN.O</span> 2.3% to $312.23      </p><p>** The <span>pharma sector ducked</span> U.S. President Donald Trump's sweeping tariffs announced on Wednesday for now</p><p>** The news came as \"a big positive to the (pharma) sector that has been under pressure from this for the last two weeks,\" UBS analysts said, adding that AbbVie and Merck, with significant ex-U.S. manufacturing, came out as \"big winners\"</p><p>** However, the administration's call for \"robust and resilient domestic manufacturing\" in the sector, suggests that it remained on its radar - UBS </p><p>** Up to last close, JNJ up 7.4%, AMGN up 17.3%, MRK down ~13%, ABBV up 15.5% so far this year   </p><p> (Reporting by Mariam Sunny in Bengaluru)</p><p> ((Mariam.ESunny@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4566","symbol_name":"资本集团","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250403:nL3N3QH1C1:1","article_id":"2524268039","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2524268039","pubTimestamp":1743688370,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-US drugmakers rise on reprieve from Trump tariffs  ** Shares of major U.S. drugmakers rise between 2% and 3% in early trading amid a broader market selloff  ** Johnson & Johnson JNJ.N rises 2.4% to $159.07, Merck MRK.N 2.2% to $88.33, AbbVie ABBV.N 2.5% to $210.28, Amgen AMGN.O 2.3% to $312.23      ** The pharma sector ducked U.S. President Donald Trump's sweeping tariffs announced on Wednesday for now** The news came as \"a big positive to the  sector that has been under pressure from this for the last two weeks,\" UBS analysts said, adding that AbbVie and Merck, with significant ex-U.S.manufacturing, came out as \"big winners\"** However, the administration's call for \"robust and resilient domestic manufacturing\" in the sector, suggests that it remained on its radar - UBS ** Up to last close, JNJ up 7.4%, AMGN up 17.3%, MRK down ~13%, ABBV up 15.5% so far this year     ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4566":"资本集团","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU1221951129.SGD":"NORDEA 1 STABLE RETURN \"HM\" (SGDHDG) INC","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","BK4504":"桥水持仓","LU0098860793.USD":"FRANKLIN INCOME \"A\" INC","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4550":"红杉资本持仓","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","SG9999014567.USD":"UOB UNITED INCOME FOCUS TRUST FUND (USD) ACC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","LU1496350502.SGD":"FRANKLIN DIVERSIFIED DYNAMIC \"A\" (SGDHDG) ACC","LU2237443465.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) INC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","JNJ":"强生","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","SG9999002232.USD":"Allianz Global High Payout USD","LU1003077747.HKD":"BGF GLOBAL EQUITY INCOME \"A6\" (HKDHDG) INC","LU1941712264.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"A\" (USD) INC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","SG9999001176.USD":"United Global Healthcare Acc USD","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","AMGN":"安进","ABBV":"艾伯维公司","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","MRK":"默沙东","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","IE00B42XCP33.USD":"GUINNESS GLOBAL EQUITY INCOME \"C\" (USD) INC","SG9999014542.SGD":"United Income Focus Trust Acc SGD","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","LU2361044865.SGD":"WELLINGTON US QUALITY GROWTH \"A\" (SGDHDG) ACC","LU2129689605.HKD":"FRANKLIN GLOBAL INCOME \"A\" (HKD) INC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD"},"translate_title":"嗡嗡声——美国制药商因特朗普关税暂缓而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABBV":0.9,"MRK":0.9,"AMGN":0.9,"JNJ":0.9},"content_text":"BUZZ-US drugmakers rise on reprieve from Trump tariffs  ** Shares of major U.S. drugmakers rise between 2% and 3% in early trading amid a broader market selloff  ** Johnson & Johnson JNJ.N rises 2.4% to $159.07, Merck MRK.N 2.2% to $88.33, AbbVie ABBV.N 2.5% to $210.28, Amgen AMGN.O 2.3% to $312.23      ** The pharma sector ducked U.S. President Donald Trump's sweeping tariffs announced on Wednesday for now** The news came as \"a big positive to the (pharma) sector that has been under pressure from this for the last two weeks,\" UBS analysts said, adding that AbbVie and Merck, with significant ex-U.S. manufacturing, came out as \"big winners\"** However, the administration's call for \"robust and resilient domestic manufacturing\" in the sector, suggests that it remained on its radar - UBS ** Up to last close, JNJ up 7.4%, AMGN up 17.3%, MRK down ~13%, ABBV up 15.5% so far this year    (Reporting by Mariam Sunny in Bengaluru) ((Mariam.ESunny@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2524268039","isCrawlerRequest":true}